Lowe, III; John A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lowe, III; John A..The latest application filed is for "spiro-lactam nmda receptor modulators and uses thereof".
Company Profile
19.43.43
- Lowe, III; John A. - Stonington CT
- Lowe, III; John A. - New York NY
Patent Activity
| Patent | Date |
|---|---|
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20220151992 - Lowe, III; John A. ; et al. | 2022-05-19 |
| Bicyclic inhibitors of histone deacetylase Grant 11,286,256 - Fuller , et al. March 29, 2 | 2022-03-29 |
| Prodrugs of secondary amine compounds Grant 11,225,490 - Blumberg , et al. January 18, 2 | 2022-01-18 |
| Bicyclic inhibitors of histone deacetylase Grant 11,225,479 - Fuller , et al. January 18, 2 | 2022-01-18 |
| Substituted pyridines as inhibitors of histone deacetylase Grant 11,225,475 - Fuller , et al. January 18, 2 | 2022-01-18 |
| Hetero-halo Inhibitors Of Histone Deacetylase App 20210277007 - Jefson; Martin R. ; et al. | 2021-09-09 |
| Bicyclic Inhibitors Of Histone Deacetylase App 20210276977 - Fuller; Nathan Oliver ; et al. | 2021-09-09 |
| Inhibitors Of Histone Deacetylase App 20210276978 - Fuller; Nathan Oliver ; et al. | 2021-09-09 |
| Spiro-lactam NMDA receptor modulators and uses thereof Grant 11,077,094 - Lowe, III , et al. August 3, 2 | 2021-08-03 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20210155632 - Lowe, III; John A. ; et al. | 2021-05-27 |
| Bicyclic Inhibitors Of Histone Deacetylase App 20210147410 - Fuller; Nathan Oliver ; et al. | 2021-05-20 |
| Bicyclic Inhibitors Of Histone Deacetylase App 20210122748 - Fuller; Nathan Oliver ; et al. | 2021-04-29 |
| Prodrugs of secondary amine compounds Grant 10,954,250 - Blumberg , et al. March 23, 2 | 2021-03-23 |
| Bicyclic Inhibitors Of Histone Deacetylase App 20210053964 - Fuller; Nathan Oliver ; et al. | 2021-02-25 |
| Hetero-halo inhibitors of histone deacetylase Grant 10,919,902 - Jefson , et al. February 16, 2 | 2021-02-16 |
| Bicyclic inhibitors of histone deacetylase Grant 10,793,567 - Fuller , et al. October 6, 2 | 2020-10-06 |
| Potassium channel modulators Grant 10,774,064 - Eriksen , et al. Sept | 2020-09-15 |
| Hetero-halo Inhibitors Of Histone Deacetylase App 20200247814 - Kind Code | 2020-08-06 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20200206189 - Lowe, III; John A. ; et al. | 2020-07-02 |
| Bicyclic inhibitors of histone deacetylase Grant 10,696,673 - Fuller , et al. June 30, 2 | 2020-06-30 |
| Bicyclic Inhibitors Of Histone Deacetylase App 20200148678 - Fuller; Nathan Oliver ; et al. | 2020-05-14 |
| Prodrugs of Secondary Amine Compounds App 20200087317 - Blumberg; Laura Cook ; et al. | 2020-03-19 |
| Bicyclic inhibitors of histone deacetylase Grant 10,519,149 - Fuller , et al. Dec | 2019-12-31 |
| Bicyclic Inhibitors Of Histone Deacetylase App 20190337953 - Fuller; Nathan Oliver ; et al. | 2019-11-07 |
| Spiro-lactam NMDA receptor modulators and uses thereof Grant 10,441,571 - Lowe, III , et al. Oc | 2019-10-15 |
| Spiro-lactam NMDA receptor modulators and uses thereof Grant 10,441,572 - Lowe, III , et al. Oc | 2019-10-15 |
| Heterobicyclic N-aminophenyl-amides as inhibitors of histone deacetylase Grant 10,421,756 - Jefson , et al. Sept | 2019-09-24 |
| Potassium Channel Modulators App 20190218200 - Eriksen; Birgitte Langer ; et al. | 2019-07-18 |
| Spiro-lactam NMDA receptor modulators and uses thereof Grant 10,316,041 - Lowe, III , et al. | 2019-06-11 |
| Spiro-lactam NMDA receptor modulators and uses thereof Grant 10,273,239 - Lowe, III , et al. | 2019-04-30 |
| Spiro-lactam NMDA receptor modulators and uses thereof Grant 10,253,032 - Lowe, III , et al. | 2019-04-09 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20180250268 - Lowe, III; John A. ; et al. | 2018-09-06 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20180250267 - Lowe, III; John A. ; et al. | 2018-09-06 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20180244680 - Lowe, III; John A. ; et al. | 2018-08-30 |
| Spiro-lactam NMDA receptor modulators and uses thereof Grant 10,052,308 - Lowe, III , et al. August 21, 2 | 2018-08-21 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20180215767 - Lowe, III; John A. ; et al. | 2018-08-02 |
| Bicyclic Inhibitors Of Histone Deacetylase App 20180215759 - Fuller; Nathan Oliver ; et al. | 2018-08-02 |
| Hetero-halo Inhibitors Of Histone Deacetylase App 20180194769 - Jefson; Martin R. ; et al. | 2018-07-12 |
| Heterobicyclic N-aminophenyl-amides As Inhibitors Of Histone Deacetylase App 20180194760 - JEFSON; Martin R. ; et al. | 2018-07-12 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20180179218 - Lowe, III; John A. ; et al. | 2018-06-28 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20180179217 - Lowe, III; John A. ; et al. | 2018-06-28 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20180155354 - Lowe, III; John A. ; et al. | 2018-06-07 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20180127430 - Lowe, III; John A. ; et al. | 2018-05-10 |
| Potassium Channel Modulators App 20170355708 - Jefson; Martin R. ; et al. | 2017-12-14 |
| Spiro-lactam NMDA receptor modulators and uses thereof Grant 9,828,384 - Lowe, III , et al. November 28, 2 | 2017-11-28 |
| Pyridazine derivatives, compositions and methods for treating cognitive impairment Grant 9,801,879 - Lowe, III October 31, 2 | 2017-10-31 |
| Spiro-lactam NMDA receptor modulators and uses thereof Grant 9,758,525 - Lowe, III , et al. September 12, 2 | 2017-09-12 |
| Spiro-lactam NMDA receptor modulators and uses thereof Grant 9,738,650 - Lowe, III , et al. August 22, 2 | 2017-08-22 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20170231956 - Lowe, III; John A. ; et al. | 2017-08-17 |
| Spiro-lactam NMDA receptor modulators and uses thereof Grant 9,708,335 - Lowe, III , et al. July 18, 2 | 2017-07-18 |
| Spiro-lactam NMDA receptor modulators and uses thereof Grant 9,579,304 - Lowe, III , et al. February 28, 2 | 2017-02-28 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20160368926 - Lowe, III; John A. ; et al. | 2016-12-22 |
| Spiro-lactam NMDA receptor modulators and uses thereof Grant 9,512,134 - Lowe, III , et al. December 6, 2 | 2016-12-06 |
| Spiro-lactam NMDA receptor modulators and uses thereof Grant 9,504,670 - Lowe, III , et al. November 29, 2 | 2016-11-29 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20160289240 - Lowe, III; John A. ; et al. | 2016-10-06 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20160122359 - Lowe, III; John A. ; et al. | 2016-05-05 |
| Pyridazine Derivatives, Compositions And Methods For Treating Cognitive Impairment App 20160008357 - Lowe, III; John A. | 2016-01-14 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20150376195 - Lowe, III; John A. ; et al. | 2015-12-31 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20150368253 - Lowe, III; John A. ; et al. | 2015-12-24 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20150368252 - Lowe, III; John A. ; et al. | 2015-12-24 |
| Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20150368254 - Lowe, III; John A. ; et al. | 2015-12-24 |
| Pyridazine derivatives, compositions and methods for treating cognitive impairment Grant 9,145,372 - Lowe, III September 29, 2 | 2015-09-29 |
| Prodrugs of Secondary Amine Compounds App 20150210712 - Blumberg; Laura Cook ; et al. | 2015-07-30 |
| Lrrk2 Inhibitors App 20140205537 - Bounaud; Pierre-Yves ; et al. | 2014-07-24 |
| Pyridazine Derivatives, Compositions And Methods For Treating Cognitive Impairment App 20130237545 - Lowe, III; John A. | 2013-09-12 |
| Benzodiazepine Derivatives, Compositions And Methods For Treating Cognitive Impairment App 20130237530 - Lowe, III; John A. | 2013-09-12 |
| Bicyclic [3.1.0] heteroaryl amides as type 1 glycine transport inhibitors Grant 8,124,639 - McHardy , et al. February 28, 2 | 2012-02-28 |
| Bicyclic [3.1.0] Heteroaryl Amides As Type 1 Glycine Transport Inhibitors App 20100324020 - McHardy; Stanton F. ; et al. | 2010-12-23 |
| 2-amino-6-(2,4,5-substituted-phenyl)-pyridines Grant 6,803,470 - Lowe, III , et al. October 12, 2 | 2004-10-12 |
| Substituted aromatic ethers as inhibitors of glycine transport Grant 6,784,299 - Lowe, III August 31, 2 | 2004-08-31 |
| 6-phenyl-pyridin-2-ylamine derivatives Grant 6,235,747 - Lowe, III , et al. May 22, 2 | 2001-05-22 |
| Substituted benzylamino nitrogen containing non-aromatic heterocycles Grant 5,721,255 - Howard , et al. February 24, 1 | 1998-02-24 |
| Azabicyclo derivatives for treatment of urinary incontinence Grant 5,519,033 - Rosen , et al. May 21, 1 | 1996-05-21 |
| Substituted tetrahydrobenzazepinones Grant 5,484,917 - Lowe, III January 16, 1 | 1996-01-16 |
| Pharmaceutical agents for treatment of urinary incontinence Grant 5,340,826 - Rosen , et al. August 23, 1 | 1994-08-23 |
| Quinuclidine therapeutic agents Grant 5,162,339 - Lowe, III November 10, 1 | 1992-11-10 |
| Heterocycylic-substituted quinoline-carboxylic acids Grant 5,037,834 - Brighty , et al. August 6, 1 | 1991-08-06 |
| Piperazinyl-heterocyclic compounds Grant 4,883,795 - Lowe, III , et al. November 28, 1 | 1989-11-28 |
| Quinazolinediones and pyridopyrimidinediones Grant 4,880,810 - Lowe, III November 14, 1 | 1989-11-14 |
| Aryl piperazinyl-(C.sub.2 or C.sub.4) alkylene heterocyclic compounds having neuroleptic activity Grant 4,831,031 - Lowe, III , et al. May 16, 1 | 1989-05-16 |
| Quinazolinediones and pyridopyrimidinediones Grant 4,797,403 - Lowe, III January 10, 1 | 1989-01-10 |
| Process for (1H)-isoindolin-1-one-3-carboxylic acid Grant 4,730,056 - Lowe, III March 8, 1 | 1988-03-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 